Literature DB >> 15083749

Long-term durable benefit after whole lung lavage in pulmonary alveolar proteinosis.

M Beccaria1, M Luisetti, G Rodi, A Corsico, M C Zoia, S Colato, P Pochetti, A Braschi, E Pozzi, I Cerveri.   

Abstract

Whole lung lavage (WLL) is still the gold-standard therapy for pulmonary alveolar proteinosis (PAP). The few studies on the duration of the effect of WLL, belonging to a rather remote period, show significant but transient benefits. In 21 patients with idiopathic PAP, the duration of any benefit and, in 16 of them, the time course of lung function improvement (at baseline, 1 week, 6 months, 1 yr and then every 2 yrs after WLL) were evaluated. The present WLL technique takes longer, is invasively monitored and partially modified with respect to past techniques. More than 70% of patients remained free from recurrent PAP at 7 yrs. The bulk of the improvement in spirometric results was almost completely gained in the immediate post-WLL period due to the efficient clearance of the alveoli. At a median of 5 yrs, recovery of diffusing capacity of the lung for carbon monoxide was incomplete (75 +/- 19% of the predicted value) and there were residual gas exchange abnormalities (alveolar to arterial oxygen tension difference 3.6 +/- 1.5 kPa (27 +/- 11 mmHg)) and exercise limitation, probably explained by engorgement of lymphatic vessels. In conclusion, whole lung lavage for idiopathic pulmonary alveolar proteinosis is currently a safe procedure in an experienced setting, and provides long-lasting benefits in the majority of patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15083749     DOI: 10.1183/09031936.04.00102704

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  48 in total

1.  Respiratory mechanics during repeated lung lavages in pulmonary alveolar proteinosis.

Authors:  Vittorio Antonaglia; Massimo Ferluga; Nicola Bianco; Pier Paolo Accolla; Walter A Zin
Journal:  Intern Emerg Med       Date:  2012-03-17       Impact factor: 3.397

2.  Novel method of noninvasive ventilation supported therapeutic lavage in pulmonary alveolar proteinosis proves to relieve dyspnea, normalize pulmonary function test results and recover exercise capacity: a short communication.

Authors:  Szymon Skoczynski; Katarzyna Wyskida; Patrycja Rzepka-Wrona; Magdalena Wyskida; Ewa Uszok-Gawel; Dawid Bartocha; Lukasz Krzych; Wladysław Pierzchala; Adam Barczyk
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

3.  Hereditary pulmonary alveolar proteinosis: pathogenesis, presentation, diagnosis, and therapy.

Authors:  Takuji Suzuki; Takuro Sakagami; Lisa R Young; Brenna C Carey; Robert E Wood; Maurizio Luisetti; Susan E Wert; Bruce K Rubin; Katharine Kevill; Claudia Chalk; Jeffrey A Whitsett; Carrie Stevens; Lawrence M Nogee; Ilaria Campo; Bruce C Trapnell
Journal:  Am J Respir Crit Care Med       Date:  2010-07-09       Impact factor: 21.405

4.  Reply.

Authors:  D Bhattacharyya
Journal:  Med J Armed Forces India       Date:  2013-04

5.  Primary alveolar proteinosis - A report of two cases.

Authors:  D Bhattacharyya; M S Barthwal; C D S Katoch; Maj Gen S Rohatgi; S Hasnain; S P Rai; A Arora
Journal:  Med J Armed Forces India       Date:  2012-08-16

6.  Pulmonary alveolar proteinosis and successful therapy with combined lavage procedures: Case reports.

Authors:  Nalan Demır Firat; Aydin Cıledağ; Pinar Akin Kabalak; Demet Karnak; Başak Ceyda Meco; Zekerıyya Alanoğlu; Neslıhan Alkiş
Journal:  Exp Ther Med       Date:  2011-03-18       Impact factor: 2.447

7.  Long-Term Safety and Efficacy of Gene-Pulmonary Macrophage Transplantation Therapy of PAP in Csf2ra-/- Mice.

Authors:  Paritha Arumugam; Takuji Suzuki; Kenjiro Shima; Cormac McCarthy; Anthony Sallese; Matthew Wessendarp; Yan Ma; Johann Meyer; Diane Black; Claudia Chalk; Brenna Carey; Nico Lachmann; Thomas Moritz; Bruce C Trapnell
Journal:  Mol Ther       Date:  2019-07-02       Impact factor: 11.454

8.  A plasmapheresis protocol for refractory pulmonary alveolar proteinosis.

Authors:  Bryan Garber; Jeffrey Albores; Tisha Wang; Thanh H Neville
Journal:  Lung       Date:  2015-01-04       Impact factor: 2.584

9.  Pulmonary alveolar proteinosis with respiratory failure-anaesthetic management of whole lung lavage.

Authors:  Sunita Nandkumar; Madhavi Desai; Manju Butani; Z Udwadia
Journal:  Indian J Anaesth       Date:  2009-06

10.  Long-term inhaled granulocyte macrophage-colony-stimulating factor in autoimmune pulmonary alveolar proteinosis: effectiveness, safety, and lowest effective dose.

Authors:  Spyros A Papiris; Panagiotis Tsirigotis; Likurgos Kolilekas; Georgia Papadaki; Andriana I Papaioannou; Christina Triantafillidou; Anastasia Papaporfyriou; Anna Karakatsani; Konstantinos Kagouridis; Matthias Griese; Effrosyni D Manali
Journal:  Clin Drug Investig       Date:  2014-08       Impact factor: 2.859

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.